Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new …
![Acurx Pharmaceuticals Ibezapolstat Phase 2b Clinical Trial Success](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-polina-tankilevitch-3735698.jpg?resize=760%2C427&ssl=1)
![Acurx Pharmaceuticals Ibezapolstat Phase 2b Clinical Trial Success](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/01/pexels-polina-tankilevitch-3735698.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new …
Chiesi Farmaceutici S.p.A (“Chiesi Group”), an international, research-focused biopharmaceuticals and healthcare group, and Oak Hill …